Organicell OTC Stock Today

OCEL
 Stock
  

USD 0.014  0.001  6.67%   

Market Performance
0 of 100
Odds Of Distress
Over 96
Organicell Regenerative is selling for 0.014 as of the 1st of July 2022. This is a -6.67 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.013. Organicell Regenerative has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Organicell Regenerative Medicine are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of June 2021 and ending today, the 1st of July 2022. Click here to learn more.
Fiscal Year End
December
Business Domain
Capital Goods
Category
Healthcare
Classification
Industrials
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida. The company has 1.1 B outstanding shares. More on Organicell Regenerative Medicine

Moving together with Organicell Regenerative

0.62MRNAModerna Potential GrowthPairCorr
0.74JPMJP Morgan Chase TrendingPairCorr
0.82DISWalt Disney Fiscal Year End 9th of November 2022 PairCorr
0.77MSFTMicrosoft Corp Fiscal Year End 26th of July 2022 PairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Organicell Regenerative OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Organicell Regenerative's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Organicell Regenerative or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Organicell Regenerative generated a negative expected return over the last 90 days
Organicell Regenerative has high historical volatility and very poor performance
Organicell Regenerative has some characteristics of a very speculative penny stock
Organicell Regenerative has a very high chance of going through financial distress in the upcoming years
The company currently holds 1.24 M in liabilities with Debt to Equity (D/E) ratio of 22.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Organicell Regenerative has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Organicell Regenerative until it has trouble settling it off, either with new capital or with free cash flow. So, Organicell Regenerative's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Organicell Regenerative sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Organicell to invest in growth at high rates of return. When we think about Organicell Regenerative's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 5.83 M. Net Loss for the year was (6.3 M) with profit before overhead, payroll, taxes, and interest of 5.05 M.
Organicell Regenerative Medicine currently holds about 150.32 K in cash with (2.69 M) of positive cash flow from operations.
Roughly 46.0% of Organicell Regenerative outstanding shares are owned by corporate insiders
Latest headline from indiandefencenews.info: Global Cell Therapy and Acellular Therapy Market 2022 by Regional Outlook, Latest Trend, Share Analysis, Growth, Application and Forecast to 2030 Indian Defence News - Indian Defence News
CEORicardo Prats
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Organicell Regenerative's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellFairly Valued
Organicell Regenerative Medicine [OCEL] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with current market capitalization of 15.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Organicell Regenerative's market, we take the total number of its shares issued and multiply it by Organicell Regenerative's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Organicell Regenerative conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 1.1 B outstanding shares. Organicell Regenerative Medicine currently holds about 150.32 K in cash with (2.69 M) of positive cash flow from operations.
Check Organicell Regenerative Probability Of Bankruptcy
Ownership
Organicell Regenerative has a total of 1.1 Billion outstanding shares. Organicell Regenerative has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Organicell Ownership Details

Organicell Stock Price Odds Analysis

What are Organicell Regenerative's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Organicell Regenerative jumping above the current price in 90 days from now is roughly 96.0%. The Organicell Regenerative Medicine probability density function shows the probability of Organicell Regenerative otc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the otc stock has a beta coefficient of 1.0699. This indicates Organicell Regenerative Medicine market returns are highly reactive to returns on the market. As the market goes up or down, Organicell Regenerative is expected to follow. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Organicell Regenerative is significantly underperforming DOW.
  Odds Below 0.014HorizonTargetOdds Above 0.014
3.57%90 days
 0.014 
96.41%
Based on a normal probability distribution, the odds of Organicell Regenerative to move above the current price in 90 days from now is roughly 96.0 (This Organicell Regenerative Medicine probability density function shows the probability of Organicell OTC Stock to fall within a particular range of prices over 90 days) .

Organicell Regenerative Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Organicell Regenerative market risk premium is the additional return an investor will receive from holding Organicell Regenerative long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Organicell Regenerative. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Organicell Regenerative's alpha and beta are two of the key measurements used to evaluate Organicell Regenerative's performance over the market, the standard measures of volatility play an important role as well.

Organicell Stock Against Markets

Picking the right benchmark for Organicell Regenerative otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Organicell Regenerative otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Organicell Regenerative is critical whether you are bullish or bearish towards Organicell Regenerative Medicine at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Organicell Regenerative without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

Investing Organicell Regenerative Medicine

You need to understand the risk of investing before taking a position in Organicell Regenerative. The danger of trading Organicell Regenerative Medicine is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Organicell Regenerative is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Organicell Regenerative. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Organicell Regenerative is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please check Your Equity Center. Note that the Organicell Regenerative information on this page should be used as a complementary analysis to other Organicell Regenerative's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Organicell OTC Stock analysis

When running Organicell Regenerative price analysis, check to measure Organicell Regenerative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organicell Regenerative is operating at the current time. Most of Organicell Regenerative's value examination focuses on studying past and present price action to predict the probability of Organicell Regenerative's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Organicell Regenerative's price. Additionally, you may evaluate how the addition of Organicell Regenerative to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Is Organicell Regenerative's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organicell Regenerative. If investors know Organicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organicell Regenerative listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
15.8 M
Quarterly Revenue Growth YOY
0.45
Return On Assets
-1.86
The market value of Organicell Regenerative is measured differently than its book value, which is the value of Organicell that is recorded on the company's balance sheet. Investors also form their own opinion of Organicell Regenerative's value that differs from its market value or its book value, called intrinsic value, which is Organicell Regenerative's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organicell Regenerative's market value can be influenced by many factors that don't directly affect Organicell Regenerative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organicell Regenerative's value and its price as these two are different measures arrived at by different means. Investors typically determine Organicell Regenerative value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organicell Regenerative's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.